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Abstract
Background: The use of clinical practice guidelines envisages augmenting quality and best practice in clinical
outcomes. Generic guidelines that are not adapted for local use often fail to produce these outcomes. Adaptation is a
systematic and rigorous process that should maintain the quality and validity of the guideline, while making it more
usable by the targeted users. Diverse skills are required for the task of adaptation. Although adapting a guideline is not
a guarantee that it will be implemented, adaptation may improve acceptance and adherence to its recommendations.
Methods: We describe the process used to adapt clinical guidelines for diabetic retinopathy in Kenya, using validated
tools and manuals. A technical working group consisting of volunteers provided leadership.
Results: The process was intensive and required more time than anticipated. Flexibility in the process and concurrent
health system activities contributed to the success of the adaptation. The outputs from the adaptation include the
guidelines in different formats, point of care instruments, as well as tools for training, monitoring, quality assurance and
patient education.
Conclusion: Guideline adaptation is applicable and feasible at the national level in Kenya. However, it is labor- and time
-intensive. It presents a valuable opportunity to develop several additional outputs that are useful at the point of care.
Keywords: Clinical practice guidelines, Diabetes mellitus, Diabetic retinopathy, Guideline development, Guideline
adaptation, Kenya
Background
The first definition of clinical practice guidelines (CPG),
hereafter referred to as “guidelines,” was provided by the
Institute of Medicine (IOM) in the USA in 1990: “systemat-
ically developed statements to assist practitioners and
patient decisions about appropriate healthcare for specific
circumstances” [1]. Guidelines-related initiatives have
subsequently increased globally since the 1990s. This defin-
ition was revised in 2011 to: “statements that include
recommendations to optimize patient care that are
informed by a systematic review of the evidence and an
assessment of the benefits and harms of alternative care
options” [2]. Guidelines constitute one tool for good
decision-making in clinical practice, which has potential to
reduce variations in health care and its cost. Although a
plethora of barriers may compromise their effectiveness,
guidelines are instruments to improve the quality of care.
Guideline adaptation is potentially an efficient alterna-
tive to de novo guideline development, particularly in
resource-constrained contexts [3]. Adapting guidelines to
suit a local context may also improve local uptake of the
guidelines [4, 5]. Adaptation requires an active, systematic,
and participatory process [4] that preserves the integrity
of the transferable evidence-based recommendations.
Although this adaptation process is context-specific and
may not be transferable or generalizable, it needs to be
systematic, explicit, transparent, rigorous, and reprodu-
cible. The ADAPTE and Practice Guideline Evaluation
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and Adaptation Cycle (PGEAC) framework of adaptation
are validated approaches to conduct and document this
process [4].
The Institute of Medicine [2] has described eight
attributes of good guideline development. These are (a)
validity, (b) reliability and reproducibility, (c) clinical ap-
plicability, (d) clinical flexibility, (e) clarity, (f) documenta-
tion, (g) development by a multidisciplinary process, and
(h) plans for review. Guidelines are likely to reflect these
attributes when they are developed via a transparent
process by a multidisciplinary team without potential bias
and conflicts of interest, and supported by a systematic re-
view of the evidence [2].
This paper describes the process involved in adapting
the diabetic retinopathy (DR) guidelines for Kenya, in
order to assist others undertaking a similar endeavor.
The STEPwise survey [6] for risk factors of
non-communicable diseases in 2015 reported that diabetes
mellitus (DM) affects an estimated 2% of the Kenyan popu-
lation aged 18–69 years, with the highest proportion (5%)
being in the 45–59 years age group. Every person living
with diabetes (PLWD) is at risk of potentially blinding dia-
betic retinopathy (DR). In turn, visual loss from DR is asso-
ciated with additional morbidity, such as falls, fractures,
and difficulties with taking medications. Both DM and DR
are associated with significant morbidity, mortality, and ex-
cess health care costs. The prevalence of DM is predicted
to rise steeply over the next decade [7], and consequently
DM and DR are important public health concerns.
Effective and quality service delivery in relation to
DR in Kenya is required within the existing health
system [8–10]. Currently, there are notable gaps in
DR screening, diagnosis, referral, treatment, and
follow-up. Although screening and laser treatment are
cost-effective interventions for prevention of blindness
from DR [11], there are inequities in access to them.
Some of the services are underutilized for a variety of
reasons, while some of the services delivered are of
insufficient quality. This disparity is linked to multiple
supply and demand factors, such as variation in refer-
ral practices of diabetes care providers, screening
practices of eye care providers, integration of services,
and level of awareness of patients [9, 12, 13].
Clinical guidelines offer recommendations to im-
prove service delivery, advocate for resources, leverage
existing resources, and improve outcomes. Imple-
menting evidence-based practice guidelines for DR is
thus vital to address the gaps and prevent blindness
from DR. International guidelines for this purpose
exist, but there are no published local guidelines. This
guideline adaptation aimed to address this lack of
national guidelines. We envisaged providing a
user-friendly guideline that describes appropriate care
based on the best available scientific evidence.
Methods
We relied on adaptation instead of de novo development
of the guideline in order to avoid duplication of effort, to
use the available resources cost-effectively, and to facilitate
customization of the guidelines prepared for other income
and health system settings to reflect local context.
The process of standardizing clinical practice recom-
mendations for DR in Kenya began over a decade ago.
Several guideline documents have been produced al-
though none has been formally published as a national
guideline. Our reflection was that opportunity costs, turn-
over of experts involved in the process, and other context-
ual factors might have slowed down further development
of the guidelines. The methodology discussed here is that
followed over the last 2 years leading to the production of
the published guideline. However, we expect that a similar
process was undertaken in the previous period.
The adaptation process has been systematic, consulta-
tive, and guided by a technical working group (TWG).
Several widely used toolkits and guidelines provided a
point of entry [14–20]. We followed the tasks of adapta-
tion, as applied within the ADAPTE framework, al-
though some of the tasks were synchronized and we
often had to return to previously completed steps. The
ADAPTE process is a well-known framework for guide-
line adaptation, which consists of 3 phases and 24 steps.
Seven core principles underpin this framework, and the
TWG adopted them for this adaptation [14]. Figure 1
provides a simplified schema of our methods.
The identification of the need for the DR guidelines by
stakeholders prompted the Ophthalmic Services Unit to
constitute a steering team of five members. This team
prepared terms of reference and a list of potential mem-
bers for the TWG. At the first few meetings of the
TWG, we discussed the following: the need for the
guidelines, the feasibility of guideline development, the
required expertise, funding, work plan, outputs, and role
definition of the members. In subsequent meetings, the
topic and clinical questions were defined.
We identified the methodological resources, the clin-
ical guidelines, and the evidence for effectiveness of vari-
ous DR interventions through a literature search on
various databases including Cochrane Library, ELDIS,
Embase, Global Health, and PubMed. We also searched
the websites of agencies that develop these resources.
The search strategy (Additional file 1) was limited to re-
ports published in English from 2000 up to date.
Two TWG members conducted the literature search
and recorded the characteristics and content of retrieved
guidelines. Guidelines that did not meet the predefined
inclusion and exclusion criteria were eliminated. Two re-
viewers assessed the quality of the retrieved guidelines
using the AGREE II instrument and presented the find-
ings in a TWG meeting. All TWG members participated
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in the assessment for currency, content, consistency, ac-
ceptability, and applicability of the recommendations.
Following consensus on the results of the assessment,
guidelines suitable for adaptation were selected.
The clinical guidelines that were selected for reference
were the American Diabetes Association (ADA) Stan-
dards for Medical Care in Diabetes [21], International
Council of Ophthalmology (ICO) guidelines for diabetic
eye care [22], the Royal College of Ophthalmologists’
diabetic retinopathy guidelines [23], and the Canadian
Diabetes Association’s retinopathy guidelines [24]. We
chose the ADA and ICO guidelines as the prototypes for
DM and DR guidelines respectively and collated evi-
dence from Cochrane systematic reviews relevant to dia-
betic retinopathy. None of the guidelines contained an
adaptation template for different contexts.
We utilized the AGREE II (Appraisal of Guidelines Re-
search and Evaluation II) instrument to assess the quality
of the clinical guidelines. This instrument consists of 23
items grouped into six domains: (a) scope and purpose,
(b) stakeholder involvement, (c) rigor of development, (d)
clarity and presentation, (e) applicability, and (f) editorial
independence.
The following additional guidelines were also
reviewed, so as to identify any potential conflict in rec-
ommendations for care of diabetes and other comorbidi-
ties: Kenya national guidelines for management of
diabetes [25], Kenya national strategy for the prevention
and control of non-communicable diseases [26], and
International Diabetes Federation’s diabetes eye health
guide for health professionals [27]. Similarly, we
reviewed previous drafts of local DR guidelines.
Draft guidelines were prepared by the TWG and circu-
lated via email to all members for review. Three drafts
were circulated, with the final draft also being circulated
to external reviewers to assess content validity, clarity,
and applicability. The TWG evaluated the final draft
guidelines for the quality requirements of the AGREE II
instrument prior to release. A consensus stakeholders
meeting approved the final draft.
Pilot testing was conducted in different health care
settings in purposively selected counties that differed in
characteristics that may influence applicability. We col-
lected feedback on the usability through interviews, re-
ports, and observation. Dissemination of guidelines was
done through county coordinators, conferences, training
institutions, professional associations, social media, and
distribution of print material.
Results
Table 1 shows the results of the adaptation process in
each of the steps of the ADAPTE framework. We ap-
plied the guiding principles as exhibited in Table 2. We
further applied the AGREE II instrument to ensure qual-
ity of our draft guideline as reported below.
Scope and purpose
The TWG’s first task was to define the scope. The main op-
tions were to include only DR or diabetic eye disease as a
whole. The consensus was to limit the scope to DR because
of its unique natural history and public health implications.
The overall objective of the guideline is to reduce the pro-
portion of PLWD who go blind due to diabetic retinopathy
in Kenya through interventions for prevention, early detec-
tion, and effective treatment of DR. The adaptation process
aimed to reduce inappropriate variation in screening and
treatment, to provide a rational guide for referral, and to
use the diabetes care and eye care resources efficiently to
meet these goals. The recommendations needed to be ger-
mane to the social context, the patient pathway, and the re-
ferral systems in addition to being capable of integration
into the routine workflow. The Population, Intervention,
Professions, Outcomes and Health care system (PIPOH)
summary (Table 3) defined the clinical questions addressed
in the guidelines.
Fig. 1 Schema for the methods used in guideline adaptation
Mwangi et al. Implementation Science  (2018) 13:81 Page 3 of 9
Table 1 Adapting the guidelines using the ADAPTE process
Step Activity Result
Phase I Set up
1. Establish a resource team The Ophthalmic Services Unit constituted a steering team of five members which
developed the terms of reference and prepared a list of 25 potential members for
the technical working group (TWG), who were subsequently invited to the group
2. Determine criteria for selection and select
a topic using criteria
DR was selected because it is a public health concern and there is variation in
standards of care
3. Check if adaptation is feasible Evidence-based guidelines were already in use internationally, and there was high
interest from the Ministry of Health, clinicians, and other users to develop guidelines
4. Identify necessary resources and skills There was high level of commitment by members of the TWG. The Fred Hollows
Foundation committed to provide funds, and the required expertise was available:
retinal specialists, public eye health specialists, endocrinologists, diabetes educators,
epidemiologists, search and retrieval of information, critical appraisal, research, policy,
guideline development, and eye health systems. A need for input from other professions
in the multidisciplinary care team for type 1, type 2, and gestational diabetes was identified
5. Complete tasks of the set-up phase Members of the group decided to function as a working group coordinated by the
Ophthalmic Services Unit. A set of guiding principles to foster development of the
guidelines was adopted (Table 2). Potential conflicts of interest were explored, and
there were none to declare
6. Write the plan for adaptation A timeline for completion, list of additional resource persons to be included, list of outputs
to be developed in conjunction with the guidelines and task allocation among the TWG
members were agreed upon
Phase II Adaptation
7. Determine and clarify the question A PIPOH summary was prepared (Table 3). The areas of interest for standards of care were
determined as screening, diagnosis and management of DR, and the management of DM
in relation to DR, within the existing care pathway for PLWD in the Kenyan health system
8. Search for guidelines and other relevant
documentation
The TWG searched for relevant DR guidelines and evidence on DR interventions in
systematic reviews
9. Screen the retrieved guidelines and record
their characteristics and content
The recommendations of the guidelines for screening, diagnosis and management of DR,
and the management of DM in relation to DR was reviewed, extracted, and compiled in
summary tables. Evidence from Cochrane systematic reviews was also reviewed
10. Eliminate a large number of the retrieved
guidelines using the AGREE instrument
The rigor dimension of the AGREE II tool was utilized to eliminate guidelines that did not
meet the stipulated criteria
11. Assess the quality of the guideline The AGREE II instrument was used to scrutinize the quality of the guidelines
12. Assess the currency of the guideline The guidelines retrieved were sufficiently current, and we did not identify any new evidence
13. Assess the content of the guideline Recommendations for screening, diagnosis, grading, referral and treatment were examined
and did not differ significantly between guidelines
14. Assess the consistency of the guideline There was clear consistency between the evidence from systematic reviews, the
interpretation of the evidence, and the recommendations in the guidelines in all
the areas of interest
15. Assess the acceptability and applicability
of the recommendations
Care was taken to ensure the recommendations are not in conflict with other local
guidelines and to appraise the implications of the guidelines on health service delivery
16. Review assessments The results of the assessment of the guidelines were discussed in meetings of the TWG
17. Select among guidelines and recommendations
to create an adapted guideline
The ICO guideline for DR was the main guideline used because the recommendations
compared well with the other high-quality DR guidelines and the practice-based
recommendations were well-stated
18. Prepare a draft of the adapted guideline The facilitators of the working group compiled the results of the deliberations and wrote
the draft guideline document
Phase III Finalization
19. Seek feedback on the draft guideline from
those who would be using it
Three revisions of the draft were circulated for comment to TWG members as well as
surgeons, pediatricians, ophthalmologists, Kenya Defeat Diabetes Association, vitreoretinal
surgeons, physicians, diabetes educators for agreement and identification of gaps
20. Consult with endorsement bodies The Ministry of Health adopted the guidelines
21. Consult with developers of guidelines
used as sources
No substantive changes were made to recommendations so this step was not undertaken
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Stakeholder involvement
The Ophthalmic Services Unit at the Ministry of Health
convened a steering group of five members. They
drafted the terms of reference for a task-oriented TWG,
which were to (1) determine the scope and focus of the
required guidelines, (2) appraise the evidence and rec-
ommendations in existing DR guidelines, (3) develop the
national guideline, and (4) craft messages to be used at
the point of care, to influence practice.
The steering group identified 25 potential members of
the TWG, based on the criteria of diverse expertise, ex-
perience, representation of multiple stakeholder groups,
and commitment to the process, all aimed at increasing
both internal and external validity of the guidelines.
These members received personal invitations to partici-
pate. An average of 15 were active members of the TWG
at any given time, but the others remained involved on
the periphery and received frequent reminders to
participate remotely. Participation was through attending
meetings, email and telephone correspondence,
face-to-face consultations, availing resource documents,
reviewing drafts, providing evidence, and informal con-
sultations. This proactive integrative and flexible ap-
proach was designed to ensure ownership, external
validity, and the involvement of end users of the
guideline.
The TWG members were all volunteers with other
clinical, educational, administrative, and policy roles re-
lated to DM and DR in public, private, or faith-based
health facilities, academia, ministry of health, and pro-
fessional organizations. Participation on a volunteer
basis inferred limitation of availability, though addition-
ally, it implied indirect institutional participation of the
employer. They had diverse expertise including clinical,
public health, research, epidemiology, literature search,
systematic reviews, and health systems. Differences in
opinion were encountered in the deliberation of some
recommendations, particularly regarding the role of dif-
ferent cadres in making DR treatment decisions and
delivering treatment. This was resolved through varied
strategies: expressing judgements about values and
risks, making reference to regulation, reviewing the
evidence for role specification, and adapting the role
definition prescribed by the source guidelines and
informal consensus techniques.
We did not employ a research assistant, because the
team had skills in literature review, recent systematic re-
views on interventions for DR were available and the
Table 1 Adapting the guidelines using the ADAPTE process (Continued)
Step Activity Result
22. Acknowledge source documents The key guideline documents and other resources used have been acknowledged through
attribution
23. Plan for aftercare of the adapted guideline A review date was planned for 5 years. Monitoring indicators were also identified. Pilot-
testing has been used to check for usability. Distribution will be through electronic and
print copies
24. Produce a final document of the guideline
and other outputs
The following additional outputs were produced (along with the guideline): posters and
brochures for patient information, posters, brochures and checklist to be used by clinicians,
workshop slides for training health workers, quality assurance guidelines
Table 2 Guiding principles for guideline adaptation
Guiding principle Indicator
1. Respect for evidence-based principles in the development
of guidelines
The evidence on which the recommendations are based is included in the
guidelines
2. Ensuring that the quality of guidelines is high Well-known frameworks for guideline development were used to guide and
assess the quality of the adaptation process
3. Participation of key stakeholders to foster acceptance and
ownership of the adapted guideline and ultimately promote
its use
The involvement of stakeholders was acknowledged in reports of the adaptation
process
4. Consideration of context during adaptation to ensure
relevance for local practice and policy
The context of application of the guidelines has been explicitly stated and the
content adapted for the Kenyan health system
5. Transparency to promote confidence in the guideline
development process
The methodology in the adaptation process has been documented so that it is
accessible and reproducible
6. Flexibility to accommodate specific needs and
circumstances in the health system
The guideline presents recommendations for diverse categories of PLWD (such as
those with different stages of DR or comorbidities) who receive service in different
clinical settings
7. Respect for and acknowledgement of guideline materials
used as sources
Citation and referencing have been used to acknowledge all source documents
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existing guidelines were current. The team did not have
a health economist and did not conduct an economic
appraisal. As the guidelines were in English, we did not
require expertise in foreign languages.
The TWG considered it is important to include pa-
tients’ values and perspectives in the guidelines. A pa-
tient group was invited and PLWD who are clinicians
were included, but despite our efforts, we did not suc-
ceed in having patients directly participate in the adapta-
tion. We also aspired to have the participation of large
groups of PLWD in a way that adequately represents the
diversity of perspectives of PLWD from different geo-
graphical locations, social strata, and stages of disease.
Since we do not have a comprehensive database of
PLWD in the country, this was not feasible.
Rigor of development
We obtained high quality and current international guide-
lines. We examined the methods and the quality of the
evidence used to formulate the recommendations for in-
terventions for DR. We also considered the implications
for resources and health service delivery in Kenya. Further,
we searched for any recent evidence from systematic re-
views and for relevant domestic research. In the absence
of this, and judging the recommendations current and
evidence-based, we incorporated them in our guidelines.
The draft guidelines were subsequently reviewed by exter-
nal multidisciplinary reviewers and pilot-tested in various
health facilities. The guideline will be updated in 5 years
to incorporate any new evidence that will have emerged.
Clarity and presentation of the guideline
We used the Conference for Guideline Standardization
(COGS) checklist [20] as a guide to the content that
needed documentation, although we excluded those
items on the list that we did not consider necessary. The
adapted guideline also includes additional information
that was not in the international guidelines, such as the
pattern of diabetes in Kenya, integrating DM and DR
services, dissemination, and review plans.
In writing the guidelines, we avoided vague, nonspe-
cific, or ambiguous terms and phrases. We aimed to
produce a user-friendly guideline in which the precise
recommendations are easily identifiable and clear, and
the formatting is appropriate.
Applicability
We recognized the facilitators and barriers to the appli-
cation of this guideline in the Kenyan health system. To
overcome the barriers, the guideline provides tools to fa-
cilitate its implementation at the point of use. These in-
clude workshop slides for training guideline
implementers. Flexible 1- day training programs have
been executed at implementing health facilities, confer-
ences and training institutions, in conjunction with
guidelines dissemination. The potential resource impli-
cations (equipment, staff, and training) and resultant
work burden of applying the recommendations were
considered. A monitoring and evaluation plan has also
been included to assess adherence to recommendations
and the outcomes of the implementation.
We required data on the costs of DR services in
Kenya, but we did not undertake this as the Division of
Non-Communicable Diseases had recently undertaken
costing for diabetes services, including DR services. We
lacked a costing model for guideline adaptation at the
start of the exercise, but in our experience, the largest
cost of the adaptation process was the production,
pilot-testing, dissemination, and implementation of the
print outputs. This may be reduced with progressive en-
hancement of digital literacy of the users and increased
utilization of the electronic resources.
Editorial independence
The basic logistic needs of the adaptation process (ad-
ministrative and meeting costs), as well as the imple-
mentation costs, were funded by The Fred Hollows
Foundation. The funders did not influence the content
of the guideline. There was a 100% consensus on the de-
sired outcome of the guidelines, which is prevention of
blindness from DR. Members and funders did not have
any conflict of interest with respect to this outcome.
Context-specific modifications
Unlike the reference guidelines, the Kenyan guideline is
designed for use by both diabetes and eye care clinicians,
as well as other stakeholders in eye care. The population
of interest is all PLWD aged 12 years and over, without
any exceptions. The guideline attempts to take care of
various complexities of service delivery. The role of dif-
ferent cadres in the screening, diagnosis, and treatment
Table 3 PIPOH summary of the clinical questions
Parameter Specification
P Population All patients with diabetes mellitus who are aged ≥ 12 years
I Intervention Screening, diagnosis, referral, and management of diabetic retinopathy
P Professions (target users) Primary care workers, diabetes care providers, eye care workers, administrators, policy-makers
O Outcomes All persons living with diabetes are screened for DR at least annually and blindness from DR is prevented
H Health care setting Community, Primary, Secondary, and Tertiary level health care settings
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of DR is highlighted. Noting the variability in access to
required equipment and skills, a referral mechanism has
been determined through mapping of the services avail-
able in different facilities in the country. We found it
practical to constantly relate the guideline to the patient
pathway. Additional specifications have been made on
linking diabetes care and eye care services, clinical gov-
ernance for the services, and using the health informa-
tion management systems (HIMS) to monitor the effect
of implementation of the guidelines.
Outputs
This process has led to several outputs: (i) the national
guidelines in various formats—print copies, electronic ver-
sion, and an executive summary of the recommenda-
tions. The guideline has a national coverage and applies to
persons with any type of diabetes.' (ii) quality assurance
guidelines; (iii) mapping of DR services in the country; (iv)
posters and leaflets for patients; (v) posters and checklists
for clinicians; (vi) workshop slides for training health
workers; and (vii) monitoring and evaluation tool. These
outputs are to be used at the point of care by diabetes and
eye care clinicians, as well as by administrators and policy
makers. They were chosen because they were perceived to
increase convenience of users and to intensify user adop-
tion of the guidelines. They are in English, but they can be
translated. An executive summary of the guidelines is
published in a separate paper [12].
Feedback from pilot-testing indicated that the guideline
is useful in various clinical and geographic settings in the
country. It served an educational role for clinicians and re-
duced missed opportunities for screening and referral.
The demand for the print outputs continued after
pilot-testing. The point-of-use outputs were reported to
boost user satisfaction because they contained simplified
key messages for different users. During prospective col-
lection of feedback, the lack of a tool to guide integration
of diabetes and eye care services has been identified as a
gap, and its development is being considered.
Discussion
The process of DR guideline development in Kenya has
taken several iterative episodes. This trajectory may reflect
the intensive work that guideline adaptation entails, as well
as the capacity building that has resulted over that process.
This experience is not unique to this initiative; long time-
lines have been reported in other guideline initiatives in the
same context [28]. Contextual factors such as transitions in
the guideline development team or critical leadership may
result in delays, repetition of effort, and modification of
approach.
We did not experience a shorter time scale for adapta-
tion compared to the 2–3 year period suggested for de
novo development or shorter timelines for adaptation
[29]. This could be because we did not conduct this
guideline development process continuously and the
team of experts had other primary engagements. How-
ever, it is evident that the adaptation approach also re-
quires a heavy time commitment. From our experience,
which concurs with the literature, it is an essential pre-
requisite to realistically determine the workload, re-
sources, access to expertise, and the need for dedicated
leadership [29].
The diverse expert skills and commitment of our multi-
disciplinary TWG are a recognizable success factor for
our initiative. This is pertinent for both the internal and
external validity (generalizability) of the guidelines [4, 17].
As adaptation requires significant investment from this
team, the selection of potential TWG members is a pivotal
priority step. Kenya being one of the countries with facing
health workforce crisis [30], the major drawback we faced
was availability of the TWG members to attend face to
face meetings, as they had competing clinical and man-
agerial responsibilities. This was predictable and inexor-
able, necessitating strategies to ensure group functioning
was not interrupted.
The integrative participation method, which allowed
both in-person participation and remote participation of
the working group, helped to mitigate this constraint.
This may have provided impetus to the process and
achievement of the outcome. The enabling factor was
that both electronic communication and face-to-face
meetings were feasible, allowing for flexible engagement.
Involving patients in the process of guideline develop-
ment is recommended [1, 29], because their opinions
about the process of investigation and treatment and
their outcomes are often quite contrary to the views of
professionals. The lack of practical methods for engage-
ment of PLWD precluded it. Although there are re-
sources to guide this, such as the toolkit from Guideline
International Network [16], local literature or prece-
dence to guide such a process is lacking. Despite invita-
tion of patient representatives to attend meetings and to
review the drafts, we did not get this direct input. This
may be because this type of involvement is not instinct-
ively consistent with patient expectations or felt needs in
our setup. Recruiting diverse groups of PLWD in a rep-
resentative manner in a setting without comprehensive
databases also requires contextual strategies. These limi-
tations call for further local research.
We found that the guideline adaptation had the pat-
tern of back and forth interlinked steps. We did not fol-
low the ADAPTE steps sequentially as a stringently
linear progressive and prescriptive tool. Further, even
with the use of methodological tools, we found that there
is need to maintain focus so that the process is not stag-
gered. Clarity of the scope and significance to the patient
pathway helped to maintain focus and continuity. Focus
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helped to avoid attrition, considering that universal com-
pletion of guideline development is not the norm [1].
Similar to de novo development, adaptation requires a
review of the evidence and explicit use of valid evidence
[15]. It would have enriched the process if we had add-
itional domestic evidence. There is need for local re-
search to fill gaps in scientific knowledge regarding
interventions for DR in this population and health sys-
tem. Local evidence on economic analysis such as
cost-minimization and cost-utility evidence of the inter-
ventions is also necessary.
Adaptation itself has cost implications, and although
we did not have a large dedicated budget for the
process, we found it important to have a budget for
the variable costs. In the absence of funding for fixed
costs, we cannot provide an estimate of the funding
required. Such estimates would help to calculate the
cost-effectiveness of the process, considering the op-
portunity costs, and comparison with the cost of de
novo development. The interventions described in the
guidelines are clinically effective, but we need to in-
vestigate whether these interventions and the process
of guideline development are also cost-effective in our
setting. At present, we assume that guidelines aug-
ment the efficiency of DR services and optimize value
for every shilling invested in the health system. In
order to balance cost and accessibility of services, the
guidelines promote the use of existing resources while
aspiring to progressively mobilize the range of re-
sources that are recommended.
National guidelines for various conditions may contain
conflicting recommendations, which can be confusing for
clinicians. This is especially the case for PLWD, as they
often have comorbidities. We avoided such discrepancies
by reviewing the other diabetes-related guidelines, and we
recommend this as an important step in adaptation.
The output from the adaptation process is a guide-
line that is different from the generic guidelines (or
source guidelines) and contains additional information
that will be useful for the target user. An additional
benefit is the production of additional tools for use at
the point of care. This shows that the role of guide-
line adaptation is not limited to endorsing generic
recommendations.
This initiative has coincided with other DR activities,
such as the initial steps towards implementing regular ret-
inal screening for PLWD attending diabetes services. This
may have contributed to its success, and we can further
leverage on this to market the guidelines. Given that
countries in the African region, particularly the Eastern,
Central, and Sothern African region may face similar
needs to develop guidelines, a network or collaboration of
sharing and learning may be an efficient approach to de-
velop them.
Conclusions
Guideline adaptation is a structured investment -inten-
sive process that is feasible at the country level. Rigor
and focus are important in this process. The ADAPTE
process and AGREE II instrument are valuable tools for
this process, though it would be helpful for the generic
guidelines to have an adaptation template for other
contexts.
Multiple informational, technological, economic, so-
cial, and professional variables influence the effectiveness
of guideline adaptation. Beyond the utility of this process
in producing the outputs we required, it could also be
useful to inform the development of other guidelines in
similar contexts. Our experience has helped to provide
insights on the use of the adaptation methodology in the
African context. We have also identified guideline devel-
opment as a potential area for collaboration.
Involvement of the end user of the guidelines (diabetes
and eye health clinicians) in this adaptation process aims
to increase adherence to the guidelines. We expect that
DR services that were not routinely available to PLWD
in Kenya will now become accessible as a response to
the guidelines.
Implications for practice
Availability of a national guideline is a necessary but not
sufficient impetus to standardize patient care. The extent
to which the prevention of blindness from DR is realized
will depend on the effectiveness of guideline dissemination
and implementation, in tandem with other interventions.
Future research
An economic analysis is required to determine whether
guideline adaptation is cost-effective. Research evidence
is also required to determine the effective methods of in-
volving patients, such as DR patients, in the adaptation
process. In addition, the effectiveness of the guidelines
in reducing DR blindness will need evaluation.
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